Provider | |
---|---|
MohammadHassan Emami , PhDFull Professor
School :School of MedicineDepartment :Department of Internal MedicineResearch Center :Poursina Hakim Digestive Diseases Research Centerwork address :Isfahan University of Medical Sciences, School of medicine, Department of Internal MedicineLevel 3, Building No. 1, Isfahan Healthcare City, Aghababaei Expy Isfahan, Iran, Poursina Hakim Digestive Diseases Research Center Education :1999-2001 Subspecialty in Gastroenterology and Hepatology, Shiraz university of Medical Sciences, Iran 1989-1993 Specialty in Internal Medicine, Isfahan university of Medical Sciences, Iran 1982-1989 General Medicine, Isfahan university of Medical Sciences, Iran 1981-1982 Nuclear medicine technology, New York University Hospital, John Hopkins. USA 1980-1981 Biology, Rutgers University, New Jersey, USA 1979-1980 Engineering, Essex County College, Newark, New Jersey, USA 1978-1979 Engineering, Northeastern University, Boston, Massachusetts, USARelevant Work Experience :2021 Establishment of Pooya Hakim Bio based Company 2019 Establishment of Poursina Hakim Health Promotion & Cancer #Prevention Association 2014 Establishment of Health Company with Comprehensive Medical #Services In the field of gastrointestinal diseases (Soroosh Salamat company) 2013 Establishment of Medical Advance Science co. In the field of Health (MASIH company; this company is registered as a scientific innovative technical company the so called Danesh Bonyan by the year 2014) 2013 The National registration of Celiac Association and Development of its activities across Iran as the Iranian Association of Celiac 2007 Establishment of Cox Research Services Company #2006 Establishment of Zenderood Medical Equipment Corporation -Razi Chemical #2005 Establishment of Poursina hakim Farzanegan Publishing Company #2004 Establishment of Iranian Celiac association #2003 Establishment of Poursina hakim laboratory #2002 Establishment of Poursina hakim research center and obtain the approval in- principle for the Gastroenterology Poursina hakim research center from the chief of Development #2001 Establishment of Poursina hakim clinic #planner and Executor of Problem based learning in Navvab center and Feiz hospital in Isfahan #Collaborator of Sayyedolshohada autologous bone marrow transplantation center establishment in Isfahan #Executor of Community based research and education center of NAVVAB in Isfahan #planner and Executor of Educational technology center of IUMS. #Medical &Technical innovations: #2007 Improvement of ileal intubation technique to reach highest percentage of ileal intubation success rate at the time #2006 Adoption of a new endoscopic diagnostic criteria and prognostic scales for achalasia named Endoscopic Visual Scale for Diagnosis (EVS-Diagnosis; unpublished) and Endoscopic Visual Scale for Prognosis (EVS-Prognosis; published) #2006 TTS balloon dilation for a 4-year-old girl suffering from severe dysphagia due to epidermolysis bullosa deformitica for the first time in Iran and as one the pioneer centers in the world to use this technique for this complication. We now routinely use this treatment for referral patients in our center with excellent results. #1991 Placement of the first femoral and subclavian CVC in Isfahan for hemodialysisProfessional Memberships & Qualification :2019-Present Chairman of the board of Poursina Hakim Health Promotion & Cancer Prevention Association 2019-Present Chairman of the board of Kousar transplantation hospital & research institute 2007-Present Chairman of the board of Iranian Celiac Association 2006-Present Member of national board of internal medicine 2006-Present Member of editorial board of Iranian journal of Govaresh 2006-Present Member of American Gastroenterology Association #2005-Present Member of the Board of Gastroenterology #2005-Present Member of the board of trustees of Hojjatieh hospital #2004-Present Member of the board of kanon hamd iranaian #2001-Present Chairman of the board of Poursina hakim holding InstituteExtra Curricular Activities/ Interest(personal url) :Establishment and construction of Baqerololum cultural center in Shahrekord with 3000 Square meters infrastructure. Fundation of loan center in Poursina Hakim holding company to support members with an advance in case of emergency needs. Founding an account for financial assistance to indigent patients based on charities. Establishing a gluten free factory for patients suffering from celiac disease on the base of charities to produce good quality and low price diet and source of sustainable finance for development of Iranian Celiac Association in goals, services and expansion of celiac branches in different provinces (Currently, 18 provinces). Publication of “Haghighat nameh” (the truth letter), the poetry ethical educational book, effect of the deceased Ayatollah Mohammad Baqer Emami (my rdfather). Seven months attending the battlefield in the time of imposed war. Being an active member of several charity centers working in different subjects for deprived people.Grants & Awards :Patents :Presentations & Poster Sessions :1. Survey graphene quantum dots composite based Electrochemiluminescence Methods for Improvement the Detection of Carcinoembryonic Antigen in the Early Stages of Colorectal cancers. Fatemeh Maghool, Mohammad Hassan Emami, Safoora Mohammadzadeh, Samaneh Mohammadzadeh. ICIA 2021, Iran 2. The Circulating Midkine in the Newly Diagnosed Celiac Disease: Clinical Implications, Mohammad Hassan Emami, Shima Soltani, Nahid Eskandari, Mohsen Masjedi., ICIA 2021, Iran 3. Effect of Transfection of Recombinant shPD1 Gene on Cytotoxicity of CD8- T Cells, Samane Mohammadzadeh, Prof. Mohammad Hassan Emami, Fatemeh Maghool , ICIA 2021, Iran 4. Effects of Ziziphus Jujuba on induced oxidative stress by Lead in colorectal, Samane Mohammadzadeh, Mohammad Hassan Emami, Fatemeh Maghool, Safoora Mohammadzadeh, Aida Heidari, ICGH 2021, Iran 5. Effect of Boswellia and its gum resin on induced oxidative stress by cadmium in colorectal cancer, Fatemeh Maghool, Mohammad Hassan Emami, Samane Mohammadzadeh, Safoora Mohammadzadeh, Aida Heidari, ICGH 2021, Iran 6. Compare characteristics of mucosa associated adherent invasive Escherichia coli isolated from colorectal cancer patents, Razie Kamali, Hosein Fazeli, Mohammad Hassan Emami, Vajiheh Karbasizade, Fatemeh Maghool, Alireza Fahim, ICGH 2021, Iran 7. Survey the Electrochemiluminescence Methods for Improvement the Detection of Carcinoembryonic Antigen in the Early Stages of Colon and Rectal Cancers, Safoora Mohammadzadeh, Mohammad Hassan Emami, Fatemeh Maghool, Samane Mohammadzadeh, ICGH 2021, Iran 8. Effects of Arsenic on the macrophages in colorectal malignancy, Fatemeh Maghool, Mohammad Hassan Emami, Samane Mohammadzadeh, Safoora Mohammadzadeh, ICB 2021, Iran 9. Effects of Pomegranate fruit and Pomegranate molasses on induced oxidative stress by chromium in colorectal cancer, Samane Mohammadzadeh, Mohammad Hassan Emami, Safoora Mohammadzadeh, Fatemeh Maghool, Aida Heidari, ICB 2021, Iran 10. Tracking of carcinoembryonic antigen in early stages of colorectal cancer by graphene quantum dots-Based electrochemical immunosensor and aptasensor, Safoora Mohammadzadeh, Mohammad Hassan Emami, Fatemeh Maghool, Samane Mohammadzadeh, ICB 2021, Iran 11. Effects of Elaeagnus angustifolia on induced oxidative stress by Arsenic in colorectal cancer, Aida Heidari, Mohammad Hassan Emami, Samane Mohammadzadeh, Safoora Mohammadzadeh, ICB 2021, Iran 12. Effects of Soluble Human Program Cell Death protein-1 and Tumor Cells Lysate on Cytotoxicity of CD8-T Cells, Samane Mohammadzadeh, Mohammad Hassan Emami, Fatemeh Maghool, IGCC 2021 13. Effects of curcumin/reduced graphene oxide nanocomposites on colon cancer cell lines, Safoora Mohammadzadeh, Mohammad Hassan Emami, Fatemeh Maghool, IGCC 2021, Iran 14. Phylogenetic distribution of the Escherichia col isolated from patents with colorectal cancer, Razie Kamali, Hosein Fazeli, Mohammad Hassan Emami, Vajiheh Karbasizade, Fatemeh Maghool, Alireza Fahim, IGCC 2021, Iran 15. Effect of Tumor Lysate and Selenium on Anti-Tumor Immune Responses in Colorectal Cancer, Fatemeh Maghool1, Prof. Mohammad Hassan Emami, Aida Heidari, ICBMB 2020, Iran 16. Effects of PD-1/PD-L1 Blockers and Selenium on Augmentation of Anti-Tumor Immune Responses in the Colorectal Cancer, Samane Mohammadzadeh, Prof. Mohammad Hassan Emami, Fatemeh Maghool, ICBMB 2020, Iran. 17. Does selenium affect the expression of programmed cell death protein and its ligand in colorectal cancer? Samane Mohamadzade, Prof. Mohammad Hassan Emami, ICIBS 2020, Iran 18. Effects of PD-1/PD-L1 Blockers and Selenium on Augmentation of Anti-Tumor Immune Responses in the Colorectal Cancer, Samane Mohammadzadeh, Prof. Mohammad Hassan Emami, Fatemeh Maghool , ICBMB 2020, Iran 19. Escherichia coli infection and colorectal cancer, Fatemeh Maghool, Prof. Mohammad Hassan Emami, Aida Heidari, ICB 2020, Iran. 20. Effect of Nigella Sativa on Cadmium-Induced Toxicity in Colorectal Cancer, Samane Mohammadzadeh, Fatemeh Maghool, Prof. Mohammad Hassan Emami, ICB 2020, Iran. 21. Native Colorectal Cancer Screening Strategy, Mohammad Hassan Emami, ICGH 2020, Iran 22. Effect of Selenium on gut microbiota in Colorectal Cancer, Fatemeh Maghool, Mohammad Hassan Prof. Mohammad Hassan Emami, Samane Mohammadzadeh, ICGH 2020, Iran. 23. Effect of Black Cumin on heavy metal-induced inflammation in Colorectal Cancer, Samane Mohammadzadeh, Prof. Mohammad Hassan Emami, Fatemeh Maghool, ICGH 2020, Iran. 24. Copper compounds as anti-colorectal cancer agents, Fatemeh Maghool, Prof. Mohammad Hassan Emami, ICB2019, Iran. 25. Zinc and PD-L1 in Immunogenic Colorectal Cancer, Samane Mohamadzade, Prof. Mohammad Hassan Emami, ICB2019, Iran. 26. Cost Analyze of Inflammatory Bowel Disease in Isfahan 2017-2018.Firouzfar R, Rastin Maram Z, Shojaei Y, Toghyani A , Rezaei A, Baghaei A, Emami M. H. 18th Iranian International Congress of Gastroenterology and Hepatology. 2018; Iran. 27. Comparing Effect of Aripiprazole with Nortriptyline on severity of Irritable Bowel Syndrome (IBS). Rahimi H, Emami MH, Fayyazi, Mirdamadi N, Gharakhani R, Mirmosayyeb O, Fahim A, Poorbafrani M, Serati M, Tavakol N. 18th Iranian International Congress of Gastroenterology and Hepatology. 2018; Iran. 28. The Effect of Self-Care Program on Quality of Life for Children with Celiac Disease. Izadi Z, Ziaei Sh, Talakoub S, Emami MH. 18th Iranian International Congress of Gastroenterology and Hepatology. 2018; Iran; Iran. 29. Designing a data set for colorectal cancer. Rahimi H, Emami MH, Fayyazi E, Mirdamadi N, Gharakhani R, Mirmosayyeb O, Fahim A, Poorbafrani M, Serati M, Tavakol N. 18th Iranian International Congress of Gastroenterology and Hepatology. 2018; Iran. 30. BRAF gene mutation in Iranian familial colorectal cancer patients at risk for Lynch syndrome. Zeinalian M, Emami MH, Pourreza MR, Tabatabaiefar MA, Hashemzadeh-Chaleshtori M. 17th Iranian International Congress of Gastroenterology and Hepatology. 2017; Iran. 31. Effects of Ramadan Fasting on Dyspepsia Symptoms. Rahimi H, Fayyazi E, Emami MH, Fahim A, Tavakol N, Mahdavi SB, Marzbani E, Mirmosayyeb O. 17th Iranian International Congress of Gastroenterology and Hepatology. 2017; Iran. 32. Mechanisms of colon cancer pathogenesis: role of microbiota. Maghool F, Emami MH. 16th Iranian International Congress of Gastroenterology and Hepatology. 2016; Iran. 33. Sleep and quality of life in patients suffered from inflammatory bowel diseases: a cross sectional study. Habibi F, Habibi ME, Gharavinia A, Baradaran Mahdavi S, Akbarpour MJ, Baghaei A, Emami MH. 16th Iranian International Congress of Gastroenterology and Hepatology. 2016; Iran. 34. Autonomic nervous system and colitis. Maghool F, Emami MH. 15th Iranian International Congress of Gastroenterology and Hepatology. 2015; Iran. 35. Diagnostic value of Endoscopy for Upper GI Malignancy in a GI Clinic: A 6-Year Cross-Sectional Study. Emami MH, Ataei M, Baghaei A. 15th Iranian International Congress of Gastroenterology and Hepatology. 2015; Iran. 36. Diagnostic value of alarm symptoms in upper GI malignancy in a referral GI clinic from 2009 to 2015. Emami MH, Ataei M, Baghaei A. 15th Iranian International Congress of Gastroenterology and Hepatology. 2015; Iran. 37. Efficacy of sucralfate enema in solitary rectal ulcer syndrome H Tavakkoli, M Adibi, P Emami MH, MahzouniP; Farshidfar F. Digestive Disease Week (DDW) 2008. 2008; San Diego, California, USA. 38. Formulation and physicochemical evaluation of herbal anti hemorrhoid ointment for the treatment of internal anal hemorrhoids. A. Aslani, M.H. Emami, A. Ghannadi, M. Ajdari IPSC 2008. 39. Annular pancreas Associated with Pancreaticolithiasis: A case Report. Emami MH, Adilipour H, Javani M, Gholamian E, Adhamian P, PourMorshed P, Rezaei Z, Vosoughi A.A, Riazi B, Golmohamamadi P, Momenzadeh M, Rahimi H, jamali N, Ehsan F. The Second Iranian Congress on Pancreatobiliary Disease 2008. 40. Prevalence of Congenital Pancreatic Anomalies, in an ERCP Center. Emami MH,Javani M, Adilipour H, Gholamian E, Adhamian P, PourMorshed P, B.Riazi, A.A. Vosoughi, Z.Rezaei, P.Golmohamamadi, H.Rahimi, N.jamali,F.Ehsan. The Second Iranian Congress on Pancreatobiliary Disease 2008. 41. Comparision Two Stone Extarction Instrument of ERCP Basket & Balloon. E.Gholamian, MH.Emami, P.PourMorshed, M.Javani, P.Adhamian, Rezaei Z, Adilipour H, Riazi B,Vosoughi A.A, Golmohamamadi P, Rahimi H, jamali N, Ehsan F. The Second Iranian Congress on Pancreatobiliary Disease 2008. 42. Establishing New ERCP Center: Success & Risks. Emami MH, Adhamian P, Gholamian E, Javani M, PourMorshed P, Rezaei Z, Adilipour H, Riazi B,Vosoughi A.A, Golmohamamadi P, Rahimi H, jamali N, Ehsan F. The Second Iranian Congress on Pancreatobiliary Disease 2008 43. A Case of myeloproliferative disorder presenting as autoimmune hepatitis and splenic vein thrombosis. Adilipour H,Emami MH,BasiA. The 8th Iranian Congress of Gastroenterology and Hepatology. 2008 Iran. 44. Autoimmune pancreatitis with pancreatic Mass :A case report. Golmohammadi P,Pourshams A,Emami MH,Adilipour H. The 8th Iranian Congress of Gastroenterology and Hepatology. 2008 Iran. 45. Prevalence of Billary and Gallbladder Anomalies, in an ERCP Center. Emami MH,Javani M, Adilipour H, Gholamian E, Adhamian P, PourMorshed P, B.Riazi, A.K. Vosoughi, Z.Rezaee, P.Golmohamamadi, H.Rahimi, N.jamali,F.Ehsan. The 8th Iranian Congress of Gastroenterology and Hepatology. 2008 Iran. 46. The evaluation of MLH1 and MSH2 genes mutation spectrum in HNPCC patients in Isfahan province. Amani Sh,Salehi M,Emami MH. The 8th Iranian Congress of Gastroenterology and Hepatology. 2008 Iran. 47. Relation between physical activitiy and colorectal cancer :A population-pased case –control study. Golshiri P, Emami MH, Rasooli S. The 8th Iranian Congress of Gastroenterology and Hepatology. 2008 Iran. 48. Cost effectiveness analysis of different types of colorectal cancer screening methods.Allameh Z ,Davari M, Emami MH. The 8th Iranian Congress of Gastroenterology and Hepatology. 2008 Iran. 49. Three years liver fallow up in celiac patients. kouhestani S, Emami MH, Saneian H,Tavakoli H,Adibi P,Daghaghzade H,Gholamrezaei A, Shavakhi A,Khademi M. The 8th Iranian Congress of Gastroenterology and Hepatology. 2008 Iran. 50. Efficacy of Simethicone in Preparation Prior to Upper Gastrointestinal Endoscopy. Ahsan Isfahani M, Babaei L, Gholamrezaei A, Emami MH. The 8th Iranian Congress of Gastroenterology and Hepatology. 2008 Iran. 51. Acetaminophen codeine as a premedication for colonoscopy. Ahsan Isfahani M, Babaei L, Gholamrezaei A, Emami MH. The 8th Iranian Congress of Gastroenterology and Hepatology. 2008 Iran. 52. Peutz-Jeghers syndrome with bilateral breast and ovarian cancer (case report). Taheri D, Afshar N,Mahzoni P,Emami MH,Fesharakizadeh M,Ghasem-basir MH. 21st European congress of pathology September 8-13, 2007.Turkey 53. Effects of Fasting During Ramadan On Inflammatory Bowel Disease. Tavakoli H,Emami MH, Haghdani S, Adilipour H, Tavakoli M. Iranian Congress of Gastroenterology and Hepatology. 2007. 54. Effects of fasting during Ramadan on inflammatory bowel disease, Tavakkoli H, Emami M H, Haghdani S, Adilipour H; Tavakkoli M. UEGW 2007. 2007; Paris, France. 55. The Epidemiology Of Nonhereditay Colorectal Cancer In Isfahan Province. Emami mh, nemati.a, kazemi z. The 7th International Congress of Gastroenterology and Hepatology. 2007 Iran. 56. Colorectal neoplasm and nutrition. Emami mh, Adeli m.The 7th International Congress of Gastroenterology and Hepatology. 2007 Iran 57. How frequent is celiac disease among epileptic patients? mami.mh, Taheri.h, Chitsaz.A, Etemadifar M. The 7th International Congress of Gastroenterology and Hepatology. 2007 Iran. 58. Effects of fasting during Ramadan on inflammatory bowel disease, Tavakkoli H, Emami M H, Haghdani S, Adilipour H; Tavakkoli M. The 7th International Congress of Gastroenterology and Hepatology. 2007 Iran. 59. Risk factor of ERCP therapy failure in CBD stones. RezaeeZ, EmamiMH, PooshangbagheriK, AdhamianP, javaniM, gholamianE, pourmorshedP,jamali N, riaziB,daghaghzadeh H,soleimaniM,vosooghAA. The 7th International Congress of Gastroenterology and Hepatology. 2007 Iran. 60. A new approach to gastrointestinal bleeding control of blue rubber bleb nevus syndrome Emami.MH, Haghdani.S, Mahzouni.P. The 7th International Congress of Gastroenterology and Hepatology. 2007 Iran. 61. Views of Iranian gastroenterologists and internists to hypnotherapy as a tool in management of irritable bowel syndrome. Emami.mh, Gholamrezaei.A, DaneshgarH. The 7th International Congress of Gastroenterology and Hepatology. 2007 Iran 62. Safety and efficacy of new glyceryl trinitrate suppository formula: first double blind placebo-controlled clinical trial. Emami MH, Sayedyahossein S, Aslani A. 6th Iranian congress of gastroenterology and hepatology. 2006; Iran. 63. Frequency of Microscopic colitis in diarrhoea predominant Irritable Bowel Syndrome patients, Tavakkoli, Hamid; Sheikh Esmaeili, Farshad; Emami, Mohammad Hasan; Mahzouni, Parvin; 6th ICGH 2006, Mashhad, Iran. 64. Anti-Tissue transtaminase IgA antibody in screening for Celiac Disease: Disappointing in clinical practice. kouhestani S ,Emami MH, Gholamrezaei A, Farajzadegan Z, Karimi, Baghaei Am 6th iranian congress of gastroenterology and hepatology. 2006; Iran. 65. Frequency of celiac disease among epilepsy in Isfahan. Emami mh, Taheri H, chitsaz A, Etemadifar M. 6th Iranian congress of gastroenterology and hepatology. 2006; Iran 66. Validation of a non invasive salivary test for the diagnosis of helicobacter pylori infection. Daghaghzadeh H,Salehi MR, Emami MH,Hosseini Sh. 6th iranian congress of gastroenterology and hepatology. 2006; Iran 67. Compering esophagomyotomy and pneumatic balloon dilation for achalasia; Isfahan, 2006 Emami MH, RaisiM, Tabatabaei A, Hashemi M, HaghighiM, fudeM. 6th Iranian congress of gastroenterology and hepatology. 2006; Iran 68. Celiac disease in children with FTT in Isfahan. Emami MH, kouhestani S, hashemipour M,Raisi M,Shams A,Kazemi A. XII International celiac disease Symposium 2006; New York 69. Is Routine Duodenal Biopsies justified in any patient having Upper Gastrointestinal Endoscpoy ? Dr.Emami ,Dr.Karimi Dr. Kouhestani , Dr.Baghaei , Dr.Adibi , Dr.mokarian , Dr.Raesi .XII International celiac disease Symposium 2006; New York 70. Value of Endoscopic Markers in Diagnosis of Celiac Disease. Dr.Emami, Dr.Karimi Dr. Kouhestani, Dr.Shavakhi, Dr.Tavakoli, Dr.Daghaghzadeh, Dr.Jamali. XII International celiac disease Symposium 2006; New York 71. Frequency of celiac disease in irritable Bowel syndrome. Emami MH, kouhestani S, daghaghzadeh H, hashemi, M, Rais. XII International celiac disease Symposium 2006; New York 72. Healing the mind; healing the gut. A case report of hypnotherapy as an adjuvant for the management of inflammatory bowel disease. Mohammad Hassan Emami, Ali Gholamrezaei 1st psychosomatic congress. 2005;Isfahan, Iran 73. Effect of Ramadan fasting on acute upper gastrointestinal bleeding due to peptic ulcer. Emami, MH – Rahimi. 5th Iranian congress of gastroenterology and hepatology. 2005; Iran 74. Celiac disease in children with FTT in Isfahan. Emami MH, kouhestani S, hashemipour M, Raisi M, Shams a, Kazemi A. 5th Iranian congress of gastroenterology and hepatology. 2005; Iran 75. Determination of barium Enema Sensitivity and Specificity for the diagnosis large Bowel diseases. Emami, MH, HakimianN, Hakimian MR, Basiratnia R. 5th Iranian congress of gastroenterology and hepatology. 2005; Iran 76. Is Routine Duodenal Biopsies justified in any patient having Upper Gastrointestinal Endoscpoy? Dr.Emami, Dr.Karimi Dr. Kouhestani, Dr.Baghaei, Dr.Adibi, Dr.mokarian, Dr.Raesi. 5th Iranian congress of gastroenterology and hepatology. 2005; Iran 77. Value of Endoscopic Markers in Diagnosis of Celiac Disease. Dr.Emami, Dr.Karimi Dr. Kouhestani, Dr.Shavakhi, Dr.Tavakoli, Dr.Daghaghzadeh, Dr.Jamali. 5th Iranian congress of gastroenterology and hepatology. 2005; Iran 78. Endoscopic Visual Scales Is a Reliable Index of Prognosis after Achalasia Balloon Dilation Therapy.Dr emami - haghighi - daghaghzadeh - adibi – farajzadegan. 5th Iranian congress of gastroenterology and hepatology. 2005; Iran 79. Where does hypnotherapy stand in the management of irritable bowel syndrome? A systematic review. Gholamrezaei A,Ardestani SK, Emami MH,Aslani A,SoleimaniB,Shahsavari KH.5th iranian congress of gastroenterology and hepatology. 2005; Iran 80. Balloon dilation therapy in pediatric esophageal stricture. Emami MH, Riazi B, Vosooghi AA.5th Iranian congress of gastroenterology and hepatology. 2005; Iran 81. 10-Celiac disease, complicatations, mortality and cause of Death, A3-Year follow up in Isfahan..EmamiMH , KouhestaniS, Adibi P, .Karimi, Raesi M, Dehghannejad H,Tavakoli H, Baghaei Am,Farajzadegan Z,Talebi M,Rahmani A,ShavakhiA,rahimian GhA,Rogha M, JamaliN,Amini J.5th iranian congress of gastroenterology and hepatology. 2005; Iran 82. Frequency of celiac disease in irritable Bowel syndrome. Emami MH, kouhestani S, daghaghzadeh H, hashemi, M, Rais. 5th Iranian congress of gastroenterology and hepatology. 2005; Iran 83. Diagnostic accuracy of IgA anti-tissue transglutaminase in patients suspected of having coeliac disease in Iran. Mohammad Hasan Emami, Somayeh Karimi. 5th Iranian congress of gastroenterology and hepatology. 2005; Iran 84. Effect of Imipramine on severity of inflammatory Bowel disease (IBD), a double blind control study. Emami MH, Masjedi M. 5th Iranian congress of gastroenterology and hepatology. 2005; Iran 85. Common presentations and clinical classification in a series of celiac patients in Iran. Emami, kouhestani, adibi, hashemipour, daghaghzadeh. 5th Iranian congress of gastroenterology and hepatology. 2005; Iran 86. Endoscopic visual scales is a reliable index of prognosis after achalasia balloon dilation therapy. Emami, haghaghi, daghaghzadeh, adibi, farajzadegan. World congress of gastroenterology. 2005; Canada 87. One - Week Verus, Two -week Furazolidone -Based Quadruple Therapy as the First Line Treatment for Helicobacter pylori infection. Dr.Daghaghzadeh, Dr.Emami, Dr.Karimi. World Congress of Gastroenterology. 2005 88. Endoscopic Visual Scales Is A Reliable Index Of Prognosis After Achalasia Balloon Dilation Therapy. Dr Emami - haghighi - daghaghzadeh - adibi – farajzadegan. World Congress of Gastroenterology. 2005; 89. Are Endoscopic Findings Predictive For The Presence Of H.Pylori Infection? What about Indirect Histologic Findings? Dr Emami mh, taheri h, esmaeili a, tavakoli. World Congress of Gastroenterology. 2005; 90. Formulation and a Pilot Clinical Trial of Three Glyceryl Trinitrate Suppositories for the Treatment of Chronic Anal Fissure. Aslani, A., Emami, S.M.H., Tavakoli, N., Asadi, F.World Congress of Gastroenterology. 2005; 91. Formulation and Phase I Clinical Trial of an Herbal Ointment for the Treatment of Internal Anal Hemorrhoids. Aslani, A., Emami, S.M.H., Ghannadi, A., Ajdari, M. World Congress of Gastroenterology. 2005; 92. Formulation and Evaluation of Physicochemical Properties of nitroglycerin Suppositories Aslani, N. Tavakoli, S.M.H.Emami, F. Asadi. The 9th Congress of Iranian Pharmaceutical Sciences. 2004 93. Formulation of an Herbal Ointment from Quercus, Black cumin and fenugreek and it's Clinical Evaluation for the Treatment of Hemorrhoids. Dr. A. Aslani, Dr. A. Ghanadi, Dr. S.M.H. Emami, M. Ajdary. The 10th Seminar of Iranian Pharmacy Students. 2004 #94. Formulation of Nitroglycerin Suppository for the Treatment of Anal Fissure Dr. Abolfazl Aslani, Dr. S.M.H. Emami. The 4th International Congress of Gastroenterology and Hepatology. 2004 Iran 95. Preparation and evaluation of physicochemical properties of glyceryl trinitrate suppositories in the treatment of anal fissure. A. Aslani, N. Tavakoli, S.M.H.Emami, F. Asadi.The 4th International Postgraduate Research Symposium on Pharmaceutics. 2004 96. One - Week Verus, Two -week Furazolidone -Based Quadruple Therapy as the First Line Treatment for Helicobacter pylori infection. Dr.Daghaghzadeh, Dr.Emami, Dr.Karimi. The 4th International Postgraduate Research Symposium on Pharmaceutics 97. Ferquency of Esophageal Disorders In 1169 Endoscopic Finding Esfahan – Iran. Dr. Emami - Dr.Hasani. The 4th International Postgraduate Research Symposium on Pharmaceutics 98. Is There Any Association Between Age, Gender, H, Pylori Infection And Gastoesophageal Reflux Disorder In Iran Dr. Emami - Dr. Marziye Hashemi? The 4th International Postgraduate Research Symposium on Pharmaceutics 99. Where does hypnotherapy stand in the management of irritable bowel syndrome? A systematic review. Gholamrezaei A, Ardestani SK, Emami MH. The 4th International Postgraduate Research Symposium on PharmaceuticsResearch Experience :#2005-2007 Deputy director of research, Medical school, Isfahan University of medical sciences, Isfahan, Iran #1996-1999 pro-vice-chancellor of research, Isfahan university of Medical SciencesResearch Interests :Celiac Diseases Gastrointestinal Cancer Psc Pancratobiliary GI ProceduresTeaching Experience :1374 – Present ICM 1 & ICM 2 from1374 – Present Clinical Bedside teaching to medical students Teaching Interests :Gastroentrology |